To further determine whether STAT3 activation was associated with MEK inhibition, we tested another small molecule MEK inhibitor PD98059 [51] in a different K-Ras mutant pancreatic cancer cell line, AsPC-1 (G12D). Here, KRAS is linked to pancreatic neoplasm.